The safety of prescription drug products is monitored by regulatory agencies both pre- and post-market. US and Canadian pharmacovigilance practice guidelines describe the mandatory reporting requirements for serious adverse events reported domestically, globally and in the scientific literature global surveillance. Also the requirements for the preparation of periodic adverse drug experience reports containing a critical analysis of all adverse drug events occurring quarterly or annually, depending on the age of an approved drug.
Industries served
Drugs: Prescription
SafetyCall is a licensed health care practice providing adverse incident and adverse event management services in the pharmaceutical industry.
